Literature DB >> 10938268

Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes.

R J Lewis1, K J Nielsen, D J Craik, M L Loughnan, D A Adams, I A Sharpe, T Luchian, D J Adams, T Bond, L Thomas, A Jones, J L Matheson, R Drinkwater, P R Andrews, P F Alewood.   

Abstract

omega-Conotoxins selective for N-type calcium channels are useful in the management of severe pain. In an attempt to expand the therapeutic potential of this class, four new omega-conotoxins (CVIA-D) have been discovered in the venom of the piscivorous cone snail, Conus catus, using assay-guided fractionation and gene cloning. Compared with other omega-conotoxins, CVID has a novel loop 4 sequence and the highest selectivity for N-type over P/Q-type calcium channels in radioligand binding assays. CVIA-D also inhibited contractions of electrically stimulated rat vas deferens. In electrophysiological studies, omega-conotoxins CVID and MVIIA had similar potencies to inhibit current through central (alpha(1B-d)) and peripheral (alpha(1B-b)) splice variants of the rat N-type calcium channels when coexpressed with rat beta(3) in Xenopus oocytes. However, the potency of CVID and MVIIA increased when alpha(1B-d) and alpha(1B-b) were expressed in the absence of rat beta(3), an effect most pronounced for CVID at alpha(1B-d) (up to 540-fold) and least pronounced for MVIIA at alpha(1B-d) (3-fold). The novel selectivity of CVID may have therapeutic implications. (1)H NMR studies reveal that CVID possesses a combination of unique structural features, including two hydrogen bonds that stabilize loop 2 and place loop 2 proximal to loop 4, creating a globular surface that is rigid and well defined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938268     DOI: 10.1074/jbc.M002252200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays.

Authors:  C E Wright; A D Robertson; S L Whorlow; J A Angus
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons.

Authors:  Judy L Morris; Daina I Ozols; Richard J Lewis; Ian L Gibbins; Phillip Jobling
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

Review 3.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 4.  Chemokines: integrators of pain and inflammation.

Authors:  Fletcher A White; Sonia K Bhangoo; Richard J Miller
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

5.  SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.

Authors:  Lei Wen; Sheng Yang; Haifa Qiao; Zhenwei Liu; Wenxia Zhou; Yongxiang Zhang; Peitang Huang
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

6.  Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn.

Authors:  Beth K Rycroft; Kristina S Vikman; MacDonald J Christie
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

Review 7.  Targeting chronic and neuropathic pain: the N-type calcium channel comes of age.

Authors:  Terrance P Snutch
Journal:  NeuroRx       Date:  2005-10

8.  Differentiation of venoms of predatory marine gastropods: divergence of orthologous toxin genes of closely related Conus species with different dietary specializations.

Authors:  Thomas F Duda
Journal:  J Mol Evol       Date:  2008-08-12       Impact factor: 2.395

9.  Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

Authors:  A Jayamanne; H J Jeong; C I Schroeder; R J Lewis; M J Christie; C W Vaughan
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 10.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.